_id
69148195ccc777a4e85d933b
Ticker
NGMDF
Name
NuGen Medical Devices Inc
Exchange
OTCQB
Address
18 King Street East, Toronto, ON, Canada, M5C 1C4
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.nugenmd.com
Description
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.
Last Close
0.025
Volume
-
Current Price
0.025
Change
0
Last Updated
2026-01-05T11:22:43.822Z
Image
data:image/webp;base64,UklGRkwEAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSNEBAAABCjmSbatuxSDIKTYz3CpNxcyeAkZXkeaAkWkYzphBlFNuhs8P7rvnfaajcyKCgdtGirLHNz2G9gtoarVYY24dq/sf1BpjR43CYSrRvrKnCHG7NQ6akEeKEAt01hoDnWKkp4On4hlFOD4lsIe4M9CoWOaPzMtYdJ3ju0VFGOOSojGej/hNVXaEJ9NHhczJUaZ4pwhyhk4yhaP0ZNgk0HC9de7OExRLW0UL3qMRtQPhrSUR9NiVcf+o3L6418Q9b8tR8hh7E6Fq/Kj88F7TDFL5KD4aMqKiABA0+sO8tF1SvV5V1T2Vtpc4TI0GApEJuXXxoBniLTkRCRjonE8fFe/fa57Be6b0fKe9AkgwEsvblumqysfIQE80AwRHe4zfqfUToBkmdMPijjYxFc8AwfEp0ba6IuO7RSAY43JlnylTvAMCOUP7Vbe09whwoC7gN2H7/n+34L/78P8d+P8etO+A/+/D+w43+B7oxfC+D953usH3wvtuG9+vDWvfb507Ls0Cx4pLy9xhnXt2Spoo7Zhzjwtyl51gLH5UvH1xyAsXKT6GirnRM0By46DiEMINHhvwKObGWm9YzKWyDkGeE2FvrbPMrU+hKGhd3nMILbfalCEAVlA4IFQCAACwDwCdASpAAEAAPrVKoU0nI6MiKBgLUOAWiWwAtRuhEcaK/R9tWMZCi29zHr/yQfN9oXLr/zNHWUN3snj1aklGcYxn2mlaTNZvqnIuzLKwCMmdhGsaALKAC3lNvwpKeyrLiZxquBvWfnV84PSR0p6FooQjFr6HlusXC4kAiD/xHjY4yDmAAAD+/nsvHYKpwPdYeWmfbTUNldIsgKM8R/avfOcMMNj2FQI/81qaxb9fcTi7xlzVgqLl6DOU9z/i1Kho6ocSco9U1ogNWuMdHZNzr1REcj2ib9aEcfY9mTONuHjEU1a7ixRxF35O7cMX7r19/N6d5gHRmEXtZYNiicbYJPx5KVjtWQVVbnqxZVRg73egOcB4sXcRoWufUyNlNINnZff4Nfxa2zsjt8bF/SrvUvMiBX/HQbHl/qj5KqUKLmKgrMBKDVbXPffZSHHYcwnn+nyaOLD0l6oDVlV0tEPLRp1LgIknBYiY9bTPLlOfIFUA3+r2Wqhwr0lQAjAZp8fpU3mlJvqH3cZpucDZiSuMvU/8oeRgIPL+WGQW6vAxCiyL0gAu4AtvLdd2m/izaasY+qjvsTJQO5WXNXjXIYwQWke8LSYiXLrLY7UVWZzv1rqpDpAoWigP9TsCAlnf3ta5/LBCN1ivepBcX0Ay2+G8W+A7EMoCLvTXcBXU//aLp+XyucKWDKaEzx0N1iaLR7bw2KPAiwN99DaH/5cBOl74R9UWj3OgAEhvUTGnp5puv8Xqam0ArlMQ5wtZNJ50P9xTY8p6Vim76jbDMqAWyptBLz+gAA==
Ipo Date
-
Market Cap
5675892
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
34678
Cost Of Revenue
13553
Gross Profit
21125
Operating Expenses
1229136
Operating Income
-1194458
Interest Expense
800752
Pretax Income
-1871273
Net Income
-1866741
Eps
-0.008222236185763962
Dividends Per Share
-
Shares Outstanding
227035682
Income Tax Expense
-
EBITDA
-
Operating Margin
-3444.425860776285
Total Other Income Expense Net
123937
Cash
4293372
Short Term Investments
-
Receivables
35897
Inventories
340084
Total Current Assets
4997740
Property Plant Equipment
143186
Total Assets
10193591
Payables
392820
Short Term Debt
-
Long Term Debt
17656658
Total Liabilities
18852238
Equity
-8658647
Bs_currency_symbol
CAD
Depreciation
169559
Change In Working Capital
-69154
Cash From Operations
-1054170
Capital Expenditures
75401
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-1130672
Cf_currency_symbol
CAD
PE
-
PB
-0.6555172014750111
ROE
21.55926901743425
ROA
-18.312888951499033
FCF
-1129571
Fcf Percent
-32.573129938289405
Piotroski FScore
1
Health Score
31
Deep Value Investing Score
2
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
6.8
Garp Investing Score
4.5
Growth Investing Score
4
Momentum Investing Score
6.5
Net Net Investing Score
1.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
34678
Quarters > 0 > income Statement > cost Of Revenue
13553
Quarters > 0 > income Statement > gross Profit
21125
Quarters > 0 > income Statement > operating Expenses
1229136
Quarters > 0 > income Statement > operating Income
-1194458
Quarters > 0 > income Statement > interest Expense
800752
Quarters > 0 > income Statement > pretax Income
-1871273
Quarters > 0 > income Statement > net Income
-1866741
Quarters > 0 > income Statement > eps
-0.008222236185763962
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
227035682
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-3444.425860776285
Quarters > 0 > income Statement > total Other Income Expense Net
123937
Quarters > 0 > income Statement > currency_symbol
CAD
Quarters > 0 > balance Sheet > cash
4293372
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
35897
Quarters > 0 > balance Sheet > inventories
340084
Quarters > 0 > balance Sheet > total Current Assets
4997740
Quarters > 0 > balance Sheet > property Plant Equipment
143186
Quarters > 0 > balance Sheet > total Assets
10193591
Quarters > 0 > balance Sheet > payables
392820
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
17656658
Quarters > 0 > balance Sheet > total Liabilities
18852238
Quarters > 0 > balance Sheet > equity
-8658647
Quarters > 0 > balance Sheet > currency_symbol
CAD
Quarters > 0 > cash Flow > net Income
-1866741
Quarters > 0 > cash Flow > depreciation
169559
Quarters > 0 > cash Flow > change In Working Capital
-69154
Quarters > 0 > cash Flow > cash From Operations
-1054170
Quarters > 0 > cash Flow > capital Expenditures
75401
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-1130672
Quarters > 0 > cash Flow > currency_symbol
CAD
Quarters > 0 > ratios > PE
-0.008222236185763962
Quarters > 0 > ratios > PB
-0.6555172014750111
Quarters > 0 > ratios > ROE
21.55926901743425
Quarters > 0 > ratios > ROA
-18.312888951499033
Quarters > 0 > ratios > FCF
-1129571
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-32.573129938289405
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
22121
Quarters > 1 > income Statement > cost Of Revenue
8811
Quarters > 1 > income Statement > gross Profit
13310
Quarters > 1 > income Statement > operating Expenses
1014929
Quarters > 1 > income Statement > operating Income
-992808
Quarters > 1 > income Statement > interest Expense
737057
Quarters > 1 > income Statement > pretax Income
-2323107
Quarters > 1 > income Statement > net Income
-2327247
Quarters > 1 > income Statement > eps
-0.01025057814480457
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
227035682
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-4488.079200759459
Quarters > 1 > income Statement > total Other Income Expense Net
-593242
Quarters > 1 > income Statement > currency_symbol
CAD
Quarters > 1 > balance Sheet > cash
5424044
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
17122
Quarters > 1 > balance Sheet > inventories
313348
Quarters > 1 > balance Sheet > total Current Assets
6098599
Quarters > 1 > balance Sheet > property Plant Equipment
59937
Quarters > 1 > balance Sheet > total Assets
11284025
Quarters > 1 > balance Sheet > payables
424828
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
16799455
Quarters > 1 > balance Sheet > total Liabilities
17950456
Quarters > 1 > balance Sheet > equity
-6666431
Quarters > 1 > balance Sheet > currency_symbol
CAD
Quarters > 1 > cash Flow > net Income
-2327247
Quarters > 1 > cash Flow > depreciation
163784
Quarters > 1 > cash Flow > change In Working Capital
90432
Quarters > 1 > cash Flow > cash From Operations
-709981
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-762930
Quarters > 1 > cash Flow > currency_symbol
CAD
Quarters > 1 > ratios > PE
-0.01025057814480457
Quarters > 1 > ratios > PB
-0.8514139049815412
Quarters > 1 > ratios > ROE
34.909939066346
Quarters > 1 > ratios > ROA
-20.624263062160885
Quarters > 1 > ratios > FCF
-709981
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-32.09533927037656
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
116883
Quarters > 2 > income Statement > cost Of Revenue
52293
Quarters > 2 > income Statement > gross Profit
64590
Quarters > 2 > income Statement > operating Expenses
956916
Quarters > 2 > income Statement > operating Income
-840033
Quarters > 2 > income Statement > interest Expense
671210
Quarters > 2 > income Statement > pretax Income
1569497
Quarters > 2 > income Statement > net Income
1565612
Quarters > 2 > income Statement > eps
0.00689588520274976
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
227035682
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-718.6956186956187
Quarters > 2 > income Statement > total Other Income Expense Net
3080740
Quarters > 2 > income Statement > currency_symbol
CAD
Quarters > 2 > balance Sheet > cash
6186974
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
71943
Quarters > 2 > balance Sheet > inventories
415481
Quarters > 2 > balance Sheet > total Current Assets
6964974
Quarters > 2 > balance Sheet > property Plant Equipment
7810
Quarters > 2 > balance Sheet > total Assets
12102466
Quarters > 2 > balance Sheet > payables
422934
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
15209432
Quarters > 2 > balance Sheet > total Liabilities
16326902
Quarters > 2 > balance Sheet > equity
-4224436
Quarters > 2 > balance Sheet > currency_symbol
CAD
Quarters > 2 > cash Flow > net Income
1565612
Quarters > 2 > cash Flow > depreciation
157612
Quarters > 2 > cash Flow > change In Working Capital
-177617
Quarters > 2 > cash Flow > cash From Operations
-819508
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
60500
Quarters > 2 > cash Flow > net Change In Cash
-759008
Quarters > 2 > cash Flow > currency_symbol
CAD
Quarters > 2 > ratios > PE
0.00689588520274976
Quarters > 2 > ratios > PB
-1.343585759140392
Quarters > 2 > ratios > ROE
-37.06085262032612
Quarters > 2 > ratios > ROA
12.936305708274661
Quarters > 2 > ratios > FCF
-819508
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-7.011353233575456
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
415746
Quarters > 3 > income Statement > cost Of Revenue
190770
Quarters > 3 > income Statement > gross Profit
224976
Quarters > 3 > income Statement > operating Expenses
1283659
Quarters > 3 > income Statement > operating Income
-867913
Quarters > 3 > income Statement > interest Expense
715725
Quarters > 3 > income Statement > pretax Income
506260
Quarters > 3 > income Statement > net Income
510233
Quarters > 3 > income Statement > eps
0.0022594108671838307
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
225825682
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-208.76039697315187
Quarters > 3 > income Statement > total Other Income Expense Net
1786295
Quarters > 3 > income Statement > currency_symbol
CAD
Quarters > 3 > balance Sheet > cash
6945982
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
99962
Quarters > 3 > balance Sheet > inventories
320728
Quarters > 3 > balance Sheet > total Current Assets
7802842
Quarters > 3 > balance Sheet > property Plant Equipment
9403
Quarters > 3 > balance Sheet > total Assets
12894461
Quarters > 3 > balance Sheet > payables
665772
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
17229496
Quarters > 3 > balance Sheet > total Liabilities
18566120
Quarters > 3 > balance Sheet > equity
-5671659
Quarters > 3 > balance Sheet > currency_symbol
CAD
Quarters > 3 > cash Flow > net Income
510233
Quarters > 3 > cash Flow > depreciation
158139
Quarters > 3 > cash Flow > change In Working Capital
-2134990
Quarters > 3 > cash Flow > cash From Operations
-2792190
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
405000
Quarters > 3 > cash Flow > net Change In Cash
-2398009
Quarters > 3 > cash Flow > currency_symbol
CAD
Quarters > 3 > ratios > PE
0.0022594108671838307
Quarters > 3 > ratios > PB
-0.9954128148395383
Quarters > 3 > ratios > ROE
-8.996186124729995
Quarters > 3 > ratios > ROA
3.9569936269534645
Quarters > 3 > ratios > FCF
-2792190
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-6.7160958854685315
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1009879
Annuals > 0 > income Statement > cost Of Revenue
487942
Annuals > 0 > income Statement > gross Profit
521937
Annuals > 0 > income Statement > operating Expenses
6167343
Annuals > 0 > income Statement > operating Income
-5157464
Annuals > 0 > income Statement > interest Expense
1668629
Annuals > 0 > income Statement > pretax Income
-5219044
Annuals > 0 > income Statement > net Income
-5225783
Annuals > 0 > income Statement > eps
-0.02314078254394467
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
225825682
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-510.70118301301443
Annuals > 0 > income Statement > total Other Income Expense Net
1787208
Annuals > 0 > income Statement > currency_symbol
CAD
Annuals > 0 > balance Sheet > cash
6945982
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
99962
Annuals > 0 > balance Sheet > inventories
320728
Annuals > 0 > balance Sheet > total Current Assets
7802842
Annuals > 0 > balance Sheet > property Plant Equipment
9403
Annuals > 0 > balance Sheet > total Assets
12894461
Annuals > 0 > balance Sheet > payables
665772
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
17229496
Annuals > 0 > balance Sheet > total Liabilities
18566120
Annuals > 0 > balance Sheet > equity
-5671659
Annuals > 0 > balance Sheet > currency_symbol
CAD
Annuals > 0 > cash Flow > net Income
-5225783
Annuals > 0 > cash Flow > depreciation
645730
Annuals > 0 > cash Flow > change In Working Capital
-339775
Annuals > 0 > cash Flow > cash From Operations
-4713737
Annuals > 0 > cash Flow > capital Expenditures
10375
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
11207207
Annuals > 0 > cash Flow > net Change In Cash
6481526
Annuals > 0 > cash Flow > currency_symbol
CAD
Annuals > 0 > ratios > PE
-0.02314078254394467
Annuals > 0 > ratios > PB
-0.9954128148395383
Annuals > 0 > ratios > ROE
92.13852595863045
Annuals > 0 > ratios > ROA
-40.527347362561336
Annuals > 0 > ratios > FCF
-4724112
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-4.677899035428997
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
331403
Annuals > 1 > income Statement > cost Of Revenue
166562
Annuals > 1 > income Statement > gross Profit
164841
Annuals > 1 > income Statement > operating Expenses
8372209
Annuals > 1 > income Statement > operating Income
-8040806
Annuals > 1 > income Statement > interest Expense
1236303
Annuals > 1 > income Statement > pretax Income
-9328421
Annuals > 1 > income Statement > net Income
-9362217
Annuals > 1 > income Statement > eps
-0.047016622396301444
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
199125682
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-2426.292459633739
Annuals > 1 > income Statement > total Other Income Expense Net
-51312
Annuals > 1 > income Statement > currency_symbol
CAD
Annuals > 1 > balance Sheet > cash
464456
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
20752
Annuals > 1 > balance Sheet > inventories
209285
Annuals > 1 > balance Sheet > total Current Assets
1329800
Annuals > 1 > balance Sheet > property Plant Equipment
30870
Annuals > 1 > balance Sheet > total Assets
6945736
Annuals > 1 > balance Sheet > payables
971078
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
5715478
Annuals > 1 > balance Sheet > total Liabilities
9006009
Annuals > 1 > balance Sheet > equity
-2060273
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-9362217
Annuals > 1 > cash Flow > depreciation
690840
Annuals > 1 > cash Flow > change In Working Capital
-725788
Annuals > 1 > cash Flow > cash From Operations
-6714138
Annuals > 1 > cash Flow > capital Expenditures
3022
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
7100541
Annuals > 1 > cash Flow > net Change In Cash
333006
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-0.047016622396301444
Annuals > 1 > ratios > PB
-2.4162535984308877
Annuals > 1 > ratios > ROE
454.41633220451854
Annuals > 1 > ratios > ROA
-134.7908558574642
Annuals > 1 > ratios > FCF
-6717160
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-20.26885695060093
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
152358
Annuals > 2 > income Statement > cost Of Revenue
53190
Annuals > 2 > income Statement > gross Profit
99168
Annuals > 2 > income Statement > operating Expenses
4939848
Annuals > 2 > income Statement > operating Income
-4787490
Annuals > 2 > income Statement > interest Expense
1011492
Annuals > 2 > income Statement > pretax Income
-5574747
Annuals > 2 > income Statement > net Income
-5577926
Annuals > 2 > income Statement > eps
-0.05776435517120037
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
96563460
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-3142.2636159571534
Annuals > 2 > income Statement > total Other Income Expense Net
73328
Annuals > 2 > income Statement > currency_symbol
CAD
Annuals > 2 > balance Sheet > cash
131450
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
5740
Annuals > 2 > balance Sheet > inventories
76773
Annuals > 2 > balance Sheet > total Current Assets
566832
Annuals > 2 > balance Sheet > property Plant Equipment
162803
Annuals > 2 > balance Sheet > total Assets
6849251
Annuals > 2 > balance Sheet > payables
1442392
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
7162621
Annuals > 2 > balance Sheet > total Liabilities
9111706
Annuals > 2 > balance Sheet > equity
-2262455
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-5577926
Annuals > 2 > cash Flow > depreciation
727281
Annuals > 2 > cash Flow > change In Working Capital
-1726795
Annuals > 2 > cash Flow > cash From Operations
-4881883
Annuals > 2 > cash Flow > capital Expenditures
1007
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
4846378
Annuals > 2 > cash Flow > net Change In Cash
-2285
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.05776435517120037
Annuals > 2 > ratios > PB
-1.0670207805238117
Annuals > 2 > ratios > ROE
246.54306936491554
Annuals > 2 > ratios > ROA
-81.43848137555479
Annuals > 2 > ratios > FCF
-4882890
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-32.048792974441774
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
137648
Annuals > 3 > income Statement > cost Of Revenue
45424
Annuals > 3 > income Statement > gross Profit
92224
Annuals > 3 > income Statement > operating Expenses
7808945
Annuals > 3 > income Statement > operating Income
-7671297
Annuals > 3 > income Statement > interest Expense
1223495
Annuals > 3 > income Statement > pretax Income
-7104126
Annuals > 3 > income Statement > net Income
-7107082
Annuals > 3 > income Statement > eps
-0.08107582210784964
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
87659697
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-5090078
Annuals > 3 > income Statement > operating Margin
-5573.126380332443
Annuals > 3 > income Statement > total Other Income Expense Net
1764479
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1749699
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
11225
Annuals > 3 > balance Sheet > inventories
12899
Annuals > 3 > balance Sheet > total Current Assets
2145850
Annuals > 3 > balance Sheet > property Plant Equipment
18270
Annuals > 3 > balance Sheet > total Assets
8844888
Annuals > 3 > balance Sheet > payables
878484
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
5608351
Annuals > 3 > balance Sheet > total Liabilities
7187013
Annuals > 3 > balance Sheet > equity
1657875
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-7107082
Annuals > 3 > cash Flow > depreciation
626944
Annuals > 3 > cash Flow > change In Working Capital
-227866
Annuals > 3 > cash Flow > cash From Operations
-4095357
Annuals > 3 > cash Flow > capital Expenditures
3574
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
5583980
Annuals > 3 > cash Flow > net Change In Cash
1473350
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.08107582210784964
Annuals > 3 > ratios > PB
1.3218683103370281
Annuals > 3 > ratios > ROE
-428.68623991555455
Annuals > 3 > ratios > ROA
-80.35242503918649
Annuals > 3 > ratios > FCF
-4098931
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-29.778354934325236
Annuals > 3 > health Score
16
Valuation > metrics > PE
-0.008222236185763962
Valuation > metrics > PB
-0.6555172014750111
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
21.55926901743425
Profitability > metrics > ROA
-37.35170296974232
Profitability > metrics > Net Margin
-53.8306995789838
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-1.4916703298899034
Risk > final Score
24
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.72272287561733
Liquidity > metrics > Quick Ratio
11.856972659233236
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
40
Prev Profitabilities > 1
60
Prev Profitabilities > 2
50
Prev Risks > 0
25
Prev Risks > 1
25
Prev Risks > 2
25
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:16:41.496Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-29
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-28
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.006
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-28
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.0074
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-28
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.0048
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0016
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-27
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-29
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0032
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-30
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0066
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2023-12-31
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0095
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-29
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0092
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-29
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0109
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-30
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0128
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0096
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0126
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-03-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0135
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, Canada, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, Vaccines, Veterinary, Home healthcare, and others. It also provides InsuJet that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors. NuGen Medical Devices Inc. is headquartered in Toronto, Canada.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of NuGen Medical Devices Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.006
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.